The changing prevalence of attention-deficit/hyperactivity disorder and methylphenidate prescriptions: a study of data from a random sample of insurees of the AOK Health Insurance Company in the German State of Hesse, 2000-2007.

The changing prevalence of attention-deficit/hyperactivity disorder and methylphenidate prescriptions: a study of data from a random sample of insurees of the AOK Health Insurance Company in the German State of Hesse, 2000-2007.

Item

http://www.wikidata.org/entity/Q33719113

Q33719113

about

Latest trends in ADHD drug prescribing patterns in children in the UK: prevalence, incidence and persistence Antipsychotic prescription in children and adolescents: an analysis of data from a German statutory health insurance company from 2005 to 2012.Estimation of disease incidence in claims data dependent on the length of follow-up: a methodological approach.Comorbidities in ADHD children treated with methylphenidate: a database study Prescription, dispensation and marketing patterns of methylphenidate.The occurrence of adverse drug reactions reported for attention deficit hyperactivity disorder (ADHD) medications in the pediatric population: a qualitative review of empirical studies Neurological adverse effects of methylphenidate may be misdiagnosed as meningoencephalitis Drug treatment patterns of attention-deficit/hyperactivity disorder in children and adolescents in Germany: results from a large population-based cohort study.Prevalence, determinants and spectrum of attention-deficit hyperactivity disorder (ADHD) medication of children and adolescents in Germany: results of the German Health Interview and Examination Survey (KiGGS).Mental Health Problems in a School Setting in Children and Adolescents.Prospective observational study protocol to investigate long-term adverse effects of methylphenidate in children and adolescents with ADHD: the Attention Deficit Hyperactivity Disorder Drugs Use Chronic Effects (ADDUCE) study.Psychopharmacological Prescriptions in Children and Adolescents in Germany Use of neuroenhancement drugs: prevalence, frequency and use expectations in Switzerland.ADHD in Germany: Trends in Diagnosis and Pharmacotherapy.Comparative treatment patterns, healthcare resource utilization and costs of atomoxetine and long-acting methylphenidate among children and adolescents with attention-deficit/hyperactivity disorder in Germany Methylphenidate enhances neural stem cell differentiation Psychotropic medication in children and adolescents.Correspondence (letter to the editor): Is the treatment the problem?Correspondence (letter to the editor): What about the dam break upstream?Correspondence (letter to the editor): Uncritical prescription.The Risk of Hospitalizations with Injury Diagnoses in a Matched Cohort of Children and Adolescents with and without Attention Deficit/Hyperactivity Disorder in Germany: A Database Study.How Realistic Are the Scientific Assumptions of the Neuroenhancement Debate? Assessing the Pharmacological Optimism and Neuroenhancement Prevalence Hypotheses.

P2860

Q28596811-2A78F7C4-F8E6-42DE-A566-CC87587056AA Q30773209-4E497A4B-9E47-47A6-AEC0-9A9043E46791 Q34035060-1F72C937-2457-4593-A902-DC8825B8CFB3 Q34538107-AD57EB47-2C35-4B9C-B559-8863ABD36D26 Q34851862-44229A34-2CEF-48B4-AFBC-61D8CF10FF29 Q35666363-240374BA-2E43-4868-8FCC-6DFB60C69AA6 Q35779204-8DA0A7DA-7872-4A1A-A5FA-40F887CA1134 Q36469468-342F0B78-CEB4-439E-86C4-F8F8DFD19209 Q36496686-1F02D503-35A9-48D9-8F91-F86455B0A3E5 Q36850648-88E932F8-EC5A-410D-9330-8A7675253278 Q36861122-222D8016-809B-450D-8736-8BB3E7233515 Q37067376-241C7900-349D-4D84-B21C-2893CD33BD3B Q37703273-DF7B1EB4-E005-4510-BBB1-1A71CEBBFEEB Q37736303-693F6F67-AFB9-4067-B792-6BBC2BBBF239 Q39211810-2BFBA59B-8B0B-426B-B00A-32442D0C579D Q41995641-53D21450-867B-413A-9C82-674A93C69D49 Q42413463-F02B5116-EE64-4058-AB24-6595B752F009 Q42575128-9172787C-3D7F-42FF-99C3-C9DB6B6DDB12 Q42575130-3658340C-65BF-4A06-98D6-446242169CC7 Q42575137-D6B448F2-0F4F-4580-9256-63A1B39A92AF Q45832689-7B57B61A-9BF0-4F08-9148-88058A747D69 Q49207914-5E7EB5AE-FF79-425B-8400-104F014BA6D3

P2860

The changing prevalence of attention-deficit/hyperactivity disorder and methylphenidate prescriptions: a study of data from a random sample of insurees of the AOK Health Insurance Company in the German State of Hesse, 2000-2007.

Item

http://www.wikidata.org/entity/Q33719113

description

2010 nî lūn-bûn

@nan

2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu